Polares Medical  Treating insufficiency in the function of the mitral valve

Polares’ approach has the potential to become the first-line treatment for patients with both functional and degenerative mitral regurgitation, the most common form of valvular heart disease.

Polares Medical is a clinical-stage company that is developing a unique minimally-invasive trans-catheter hemi-replacement system, PLAR system, to treat insufficiency in the function of the mitral valve. Polares’ PLAR system has demonstrated safety and clinical performance in patients under compassionate-use regulation, and the company has initiated the Early Feasibility studies in the US and Europe.

Industry

Medical Devices

Case facts

Location

Switzerland, United States

Status

Active

Involved Team

Privacy Preference Center